Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial.

Name: Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial.
Author: Silveira, C R A

Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial. — المؤلف: Silveira, C R A — BMC neurology 20190313

المؤلف: Silveira, C R A
النشر: BMC neurology 20190313
الوصف: 20 p.
الموضوعات: Aged؛ Ambroxol؛ Brain؛ Dementia؛ Double-Blind Method؛ Female؛ Humans؛ Male